Queue emerged from stealth with an autonomous pharmacy system and $12.6 million in seed funding, aiming to make prescription fulfillment faster, more accessible, and cost-effective while supporting rigorous safety and verification protocols. The company’s system is designed to address structural issues in the U.S. pharmacy market, including pharmacist shortages and negative reimbursements.
The U.S. retail pharmacy market is valued at $670.6 billion, but faces challenges such as overwhelming workloads, job dissatisfaction, and pharmacy closures. Queue was co-founded by CEO Nick Desai, a six-time venture-backed entrepreneur who previously founded Heal, and CTO Josh Liu, whose experience spans Tesla and Zipline. Liu stated, “Pharmacy in America is structurally broken. Queue is a complete reimagining of how medications get dispensed, verified, and delivered.” The company believes robotics and AI should be applied to enable greater human flourishing and connection.
Source: The Robot Report